MetLife Investment Management’s Procter & Gamble PG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $78.1M | Sell |
532,786
-10,650
| -2% | -$1.55M | 0.35% | 37 |
|
|
2026
Q1 | $78.5M | Sell |
543,436
-16,935
| -3% | -$2.57M | 0.4% | 30 |
|
|
2025
Q4 | $80.3M | Sell |
560,371
-20,922
| -4% | -$3.08M | 0.39% | 29 |
|
|
2025
Q3 | $89.3M | Sell |
581,293
-16,180
| -3% | -$2.53M | 0.43% | 26 |
|
|
2025
Q2 | $95.2M | Sell |
597,473
-34,752
| -5% | -$5.67M | 0.56% | 22 |
|
|
2025
Q1 | $108M | Sell |
632,225
-14,404
| -2% | -$2.41M | 0.58% | 21 |
|
|
2024
Q4 | $108M | Buy |
646,629
+10,436
| +2% | +$1.78M | 0.59% | 22 |
|
|
2024
Q3 | $110M | Sell |
636,193
-17,741
| -3% | -$3.01M | 0.63% | 20 |
|
|
2024
Q2 | $108M | Buy |
653,934
+84,639
| +15% | +$13.8M | 0.64% | 20 |
|
|
2024
Q1 | $92.4M | Sell |
569,295
-21,059
| -4% | -$3.3M | 0.62% | 20 |
|
|
2023
Q4 | $86.5M | Sell |
590,354
-11,115
| -2% | -$1.65M | 0.62% | 20 |
|
|
2023
Q3 | $87.7M | Sell |
601,469
-15,177
| -2% | -$2.32M | 0.68% | 21 |
|
|
2023
Q2 | $93.6M | Sell |
616,646
-32,388
| -5% | -$4.88M | 0.68% | 20 |
|
|
2023
Q1 | $96.5M | Sell |
649,034
-9,735
| -1% | -$1.39M | 0.69% | 18 |
|
|
2022
Q4 | $99.8M | Sell |
658,769
-17,820
| -3% | -$2.5M | 0.76% | 16 |
|
|
2022
Q3 | $85.4M | Sell |
676,589
-11,328
| -2% | -$1.61M | 0.71% | 16 |
|
|
2022
Q2 | $98.9M | Buy |
687,917
+35,475
| +5% | +$5.33M | 0.77% | 16 |
|
|
2022
Q1 | $99.7M | Buy |
652,442
+117,774
| +22% | +$18.4M | 0.65% | 16 |
|
|
2021
Q4 | $87.5M | Sell |
534,668
-13,592
| -2% | -$2.02M | 0.72% | 17 |
|
|
2021
Q3 | $76.6M | Sell |
548,260
-19,352
| -3% | -$2.74M | 0.69% | 17 |
|
|
2021
Q2 | $76.6M | Sell |
567,612
-19,195
| -3% | -$2.6M | 0.67% | 17 |
|
|
2021
Q1 | $79.5M | Sell |
586,807
-15,380
| -3% | -$2.01M | 0.73% | 15 |
|
|
2020
Q4 | $83.8M | Sell |
602,187
-29,042
| -5% | -$4.06M | 0.79% | 14 |
|
|
2020
Q3 | $87.7M | Sell |
631,229
-16,244
| -3% | -$2.16M | 0.96% | 9 |
|
|
2020
Q2 | $77.4M | Buy |
647,473
+4,661
| +0.7% | +$544K | 0.88% | 10 |
|
|
2020
Q1 | $70.7M | Sell |
642,812
-19,668
| -3% | -$2.36M | 0.96% | 12 |
|
|
2019
Q4 | $82.7M | Sell |
662,480
-18,578
| -3% | -$2.27M | 0.86% | 13 |
|
|
2019
Q3 | $84.7M | Sell |
681,058
-10,336
| -1% | -$1.22M | 0.93% | 12 |
|
|
2019
Q2 | $75.8M | Sell |
691,394
-19,697
| -3% | -$2.1M | 0.81% | 14 |
|
|
2019
Q1 | $74M | Sell |
711,091
-1,406
| -0.2% | -$137K | 0.8% | 14 |
|
|
2018
Q4 | $65.5M | Sell |
712,497
-11,616
| -2% | -$1.04M | 0.8% | 17 |
|
|
2018
Q3 | $60.3M | Sell |
724,113
-16,127
| -2% | -$1.32M | 0.62% | 24 |
|
|
2018
Q2 | $57.8M | Sell |
740,240
-18,429
| -2% | -$1.39M | 0.68% | 22 |
|
|
2018
Q1 | $60.1M | Sell |
758,669
-29,737
| -4% | -$2.48M | 0.71% | 20 |
|
|
2017
Q4 | $72.4M | Buy |
+788,406
| New | +$70.9M | 0.82% | 14 |
|
Other funds holding PG
MetLife Investment Management's PG Position: Q2 2026 in Review
MetLife Investment Management reduced its Procter & Gamble (PG) stake by 2% in Q2 2026, selling an estimated $1.55M and leaving 532,786 shares worth $78.1M. The position accounts for 0.35% of the portfolio, ranked #37.
MetLife Investment Management first reported a position in PG in Q4 2017 and has held it in 35 quarters since. The position peaked at $110M in Q3 2024. 3,994 funds tracked by Wall St. Rank hold PG as of Q2 2026.
- MetLife Investment Management held 532,786 shares of Procter & Gamble worth $78.1M as of Q2 2026.
- MetLife Investment Management sold 10,650 Procter & Gamble shares in Q2 2026, an estimated $1.55M.
- Procter & Gamble made up 0.35% of MetLife Investment Management's portfolio in Q2 2026, its #37 holding.
- MetLife Investment Management first reported a position in Procter & Gamble in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Procter & Gamble position peaked at $110M in Q3 2024.
- 3,994 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.